Shenzhen Neptunus Bioengineering hosted a research meeting today with several Institutions including East Money Information and Deyuan Investment, as well as some individual investors. During the research activities, the company stated that its medical instruments Sector business mainly follows an agency sales model, including some well-known domestic and international brands such as Boston Scientific, Johnson & Johnson, and Shenzhen Mindray Bio-Medical Electronics. The company's medical instruments revenue in 2023 has exceeded 12 billion yuan. Compared to the pharmaceutical business, the medical instruments business is less affected by centralized procurement. In addition, the company has management and sales elites from leading enterprises such as Boston Scientific and Siemens, ensuring professionalism and advanced management concepts in the medical instruments field. Furthermore, significant matters are still ongoing, and the company will fulfill its information disclosure obligations in a timely manner according to relevant laws and regulations.